ABVC BioPharma, Inc.

ECOC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
PRER14A Sep 11, 2026 REVISED PRELIMINARY PROXY STATEMENT
8-K Aug 27, 2026 CURRENT REPORT
PRER14A Aug 25, 2026 REVISED PRELIMINARY PROXY STATEMENT
424B4 Aug 17, 2026 PROSPECTUS SUPPLEMENT
424B4 Aug 17, 2026 PROSPECTUS SUPPLEMENT
424B4 Aug 17, 2026 PROSPECTUS SUPPLEMENT
424B4 Aug 17, 2026 PROSPECTUS SUPPLEMENT
PRER14A Aug 12, 2026 REVISED PRELIMINARY PROXY STATEMENT
10-Q Aug 12, 2026 QUARTERLY REPORT
8-K/A Aug 12, 2026 CURRENT REPORT
8-K Aug 4, 2026 CURRENT REPORT
PRE 14A Jul 28, 2026 PRELIMINARY PROXY STATEMENT
8-K Jul 2, 2026 CURRENT REPORT
10-Q May 18, 2026 QUARTERLY REPORT
NT 10-Q May 15, 2026 NOTIFICATION OF LATE FILING
POS AM Mar 27, 2026 POST-EFFECTIVE AMENDMENT NO. 5 TO FORM S-1
8-K Mar 27, 2026 CURRENT REPORT
DEF 14A Mar 5, 2026 DEFINITIVE PROXY STATEMENT
10-K Mar 3, 2026 ANNUAL REPORT
10-Q/A Mar 3, 2026 AMENDMENT NO. 1 TO FORM 10-Q
8-K Mar 3, 2026 CURRENT REPORT
PRE 14A Feb 5, 2026 PRELIMINARY PROXY STATEMENT
8-K/A Jan 16, 2026 AMENDMENT NO. 1 TO FORM 8-K
424B4 Nov 14, 2025 PROSPECTUS SUPPLEMENT
424B4 Nov 14, 2025 PROSPECTUS SUPPLEMENT
← Newer Page 1 of 32 · 793 filings Older →